Nighttime Dosing of Tolterodine Reduces Overactive Bladder–Related Nocturnal Frequency in Patients With Overactive Bladder and Nocturia
Rackley R1, Weiss J2, Guan Z3, Wang J T3, Rovner E S4 1. Cleveland Clinic Foundation, 2. Weill Medical College of Cornell University, 3. Pfizer, Inc, 4. MUSC
|
|
Abstract 146
|
|
|
Non Discussion Posters
Scientific Non Discussion Poster Session 17
|
|
|